title: Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions.
authors.affiliation: Divison of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Science Faculty, Utrecht University, PO Box 80 082, 3508 TB, Utrecht, The Netherlands, G.W.J.Frederix@uu.nl.
authors.forename: Gerardus W J
authors.initials: GW
authors.lastname: Frederix
authors.forename: Hossein
authors.initials: H
authors.lastname: Haji Ali Afzali
authors.forename: Erik J
authors.initials: EJ
authors.lastname: Dasbach
authors.forename: Robyn L
authors.initials: RL
authors.lastname: Ward
mesh_terms: D020811:Biomedical Technology / Q000191:economics*; D003657:Decision Making; D003661:Decision Support Techniques; D006801:Humans; D018803:Models, Economic; D017410:Practice Guidelines as Topic; D013673:Technology Assessment, Biomedical / Q000191:economics*; D035501:Uncertainty
references.citation: Med Decis Making. 2012 Sep-Oct;32(5):733-43
references.pmid: 22990088
references.citation: BMJ. 2011 Apr 11;342:d1766
references.pmid: 21482590
references.citation: Diabetes Care. 2003 Nov;26(11):3093-101
references.pmid: 14578245
references.citation: Pharmacoeconomics. 2011 Oct;29(10):823-5
references.pmid: 21770483
references.citation: Diabetologia. 2004 Oct;47(10 ):1747-59
references.pmid: 15517152
references.citation: Value Health. 2013 Jun;16(4):670-85
references.pmid: 23796302
references.citation: J Rheumatol Suppl. 2003 Dec;68:26-30
references.pmid: 14712619
references.citation: Value Health. 2009 Jul-Aug;12(5):739-49
references.pmid: 19508655
references.citation: J Rheumatol. 2003 Apr;30(4):886-90
references.pmid: 12672223
references.citation: Pharmacoeconomics. 2013 May;31(5):361-7
references.pmid: 23529207
references.citation: Clinicoecon Outcomes Res. 2011;3:89-104
references.pmid: 21935337
references.citation: Pharmacoeconomics. 2014 Oct;32(10):943-50
references.pmid: 24986039
references.citation: Pharmacoeconomics. 2013 Nov;31(11):1031-50
references.pmid: 24234860
references.citation: JAMA. 1996 Oct 23-30;276(16):1339-41
references.pmid: 8861994
references.citation: Int J Technol Assess Health Care. 2009 Dec;25 Suppl 2:107-16
references.pmid: 20030898
references.citation: Health Econ. 2010 Jan;19(1):43-55
references.pmid: 19206080
references.citation: Semin Arthritis Rheum. 2014 Dec;44(3):271-82
references.pmid: 25086470
references.citation: Value Health. 2013 Jun;16(4):542-53
references.pmid: 23796288
references.citation: Med Decis Making. 2013 Apr;33(3):325-32
references.pmid: 22961101
references.citation: Pharmacoeconomics. 2014 Jan;32(1):47-61
references.pmid: 24263964
references.citation: Pharmacoeconomics. 2015 May;33(5):435-43
references.pmid: 25601288
references.citation: Value Health. 2012 Jan;15(1):94-105
references.pmid: 22264977
references.citation: Value Health. 2009 Jun;12 (4):409-18
references.pmid: 19900249
references.citation: Med Decis Making. 2011 Jul-Aug;31(4):675-92
references.pmid: 21653805